A comparison of 1-year substance abuse treatment outcomes in community syringe exchange participants versus other referrals

Drug and Alcohol Dependence

Volumn 97, Issue 1-2, 2008, Pages 122-129

  Neufeld, Karin ^a   King, Van ^a   Peirce, Jessica ^a   Kolodner, Ken ^a   Brooner, Robert ^a   Kidorf, Michael ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Methadone substitution; Outcomes; Syringe exchange; Treatment

Indexed keywords

COCAINE; DIAMORPHINE; METHADONE; OPIATE;

ADDICTION SEVERITY INDEX; ADULT; AFRICAN AMERICAN; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG USE; FEMALE; HAZARD RATIO; HEALTH PROGRAM; HOSPITAL ADMISSION; HUMAN; LONGITUDINAL STUDY; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; PATIENT COUNSELING; PATIENT REFERRAL; PRIORITY JOURNAL; RATING SCALE; REGRESSION ANALYSIS; STATISTICAL MODEL; SUBSTANCE ABUSE; SYRINGE EXCHANGE PROGRAM; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; UNEMPLOYMENT; URINALYSIS;

ADULT; COCAINE-RELATED DISORDERS; DATA INTERPRETATION, STATISTICAL; ETHNIC GROUPS; FEMALE; HEROIN DEPENDENCE; HUMANS; MALE; NEEDLE-EXCHANGE PROGRAMS; OPIOID-RELATED DISORDERS; PSYCHIATRIC STATUS RATING SCALES; REFERRAL AND CONSULTATION; SOCIOECONOMIC FACTORS; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME; UNEMPLOYMENT;

EID: 46649098407     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2008.03.026     Document Type: Article

References (55)

1. Ahmadi J., Kampman K., and Dackis C. Outcome predictors in cocaine dependence treatment trials. Am. J. Addict. 15 (2006) 434-439
2. Avants S.K., Margolin A., and Mckee S. A path analysis of cognitive, affective, and behavioral predictors of treatment response in a methadone maintenance program. J. Subst. Abuse 11 (2000) 215-230
3. Bluthenthal R.N., Kral A.H., Gee L., Erringer E.A., and Edlin B.R. The effect of syringe exchange use on high-risk injection drug users: a cohort study. AIDS 14 (2000) 605-611
4. Bluthenthal R.N., Gogineni A., Longshore D., and Stein M. Factors associated with readiness to change drug use among needle-exchange users. Drug Alcohol Depend. 62 (2001) 225-230
5. Booth R.E., Corsi K.F., and Mikulich-Gilbertson S.K. Factors associated with methadone maintenance treatment retention among street-recruited injection drug users. Drug Alcohol Depend. 74 (2004) 177-185
6. Brienza R.S., Stein M.D., Chen M.H., Gogineni A., Sobota M., Maksad J., Hu P., and Clarke J. Depression among needle exchange program and methadone maintenance clients. J. Subst. Abuse 18 (2000) 331-337
7. Brooner R.K., and Kidorf M. Using behavioral reinforcement to improve methadone treatment participation. Sci. Pract. Perspect. 1 (2002) 38-46
8. Brooner R.K., Greenfield L., Schmidt C.W., and Bigelow G.E. Antisocial personality disorder and HIV infection among intravenous drug abusers. Am. J. Psychiatry 150 (1993) 53-58
9. Brooner R.K., Kidorf M., King V.L., Beilenson P., Svikis D., and Vlahov D. Drug abuse treatment success among needle exchange participants. Public Health Rep. 113 (1998) 129-139
10. Brooner R.K., Kidorf M.S., King V.L., Stoller K.B., Peirce J.M., Bigelow G.E., and Kolodner K. Behavioral contingencies improve counseling attendance in an adaptive treatment model. J. Subst. Abuse Treat. 27 (2004) 223-232
11. Bruneau J., Lamothe F., Franco E., Lachance N., Desy M., Soto J., and Vincelette J. High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study. Am. J. Epidemiol. 146 (1997) 994-1002
12. Center for Substance Abuse Treatment, 2001. Code of Federal Regulations Substance Abuse and Mental Health Services Administration. 42 (Part 8).
13. Center for Disease Control and Prevention. Syringe exchange programs, United States, 2005. MMWR 56 (2007) 1164-1167
14. Ciraulo D.A., Piechniczek-Buczek J., and Iscan E.N. Outcome predictors in substance use disorders. Psychiatr. Clin. North Am. 26 (2003) 381-409
15. Des Jarlais D.C., Marmor M., Paone D., Titus S., Shi Q., Perlis T., Jose B., and Friedman S.R. HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet 348 (1996) 987-991
16. Disney E., Kidorf M., Kolodner K., King V., Peirce J., Beilenson P., and Brooner R.K. Psychiatric comorbidity is associated with drug use and HIV risk in syringe exchange participants. J. Nerv. Ment. Dis. 194 (2006) 577-583
17. Fisher D.G., Fenaughty A.M., Cagle H.H., and Wells R.S. Needle exchange and injection drug use frequency: a randomized clinical trial. J. Acquir. Immune Defic. Syndr. 33 (2003) 199-205
18. Gibson D.R., Flynn N.M., and Perales D. Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS 15 (2001) 1329-1341
19. Gibson D.R., Brand R.S., Anderson K., Kahn J.G., Perales D., and Guydish J. Two- to sixfold decreased odds of HIV risk behavior associated with use of syringe exchange. J. Acquir. Immune Defic. Syndr. 31 (2002) 237-242
20. Hagan H., McGough J.P., Thiede H., Hopkins S., Duchin J., and Alexander E.R. Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors. J. Subst. Abuse Treat. 19 (2000) 247-252
21. Hahn J.A., Vranizan K.M., and Moss A.R. Who uses needle exchange? A study of injection drug users in treatment in San Francisco, 1989-1990. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 15 (1997) 157-164
22. Heimer R. Can syringe exchange serve as a conduit to substance abuse treatment. J. Subst. Abuse Treat. 15 (1998) 183-191
23. Henderson L.A., Vlahov D., Celentano D.D., and Strathdee S.A. Readiness for cessation of drug use among recent attenders and nonattenders of a needle exchange program. J. Acquir. Immune Defic. Syndr. 32 (2003) 229-237
24. Kidorf M., and Brooner R.K. A motivational intervention for improving treatment enrollment in syringe exchange participants. Proceedings of the XVI International AIDS Conference (2006)
25. Kidorf, M., King, V.L., in press. Expanding the public health benefits of syringe exchange programs. Can. J. Psychiatry.
26. Kidorf M., Brooner R.K., King V.L., Stoller K.B., and Wertz J. Predictive validity of cocaine, sedative, and alcohol dependence diagnoses. J. Consult. Clin. Psychol. 66 (1998) 168-173
27. Kidorf M., Disney E.R., King V.L., Neufeld K., Beilenson P.L., and Brooner R.K. Prevalence of psychiatric and substance use disorders in opioid abusers in a community syringe exchange program. Drug Alcohol Depend. 74 (2004) 115-122
28. Kidorf M., Disney E., King V., Kolodner K., Beilenson P., and Brooner R.K. Challenges in motivating treatment enrollment in community syringe exchange participants. J. Urban Health 82 (2005) 456-467
29. Kidorf M., King V.L., and Brooner R.K. Counseling and psychosocial services. In: Strain E.C., and Stitzer M.L. (Eds). The Treatment of Opioid Dependence (2006), Johns Hopkins University Press, Baltimore 119-150
30. Magura S., Nwakeze P.C., and Demsky S. Pre- and in-treatment predictors of retention in methadone treatment using survival analysis. Addiction 93 (1998) 51-60
31. Marsch L.A. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis. Addiction 93 (1998) 515-532
32. McCarty D., Gustafson D.H., Wisdom J.P., Ford J., Choi D., Molfenter T., Capoccia V., and Cotter F. The Network for the Improvement of Addiction Treatment (NIATx): enhancing access and retention. Drug Alcohol Depend. 88 (2007) 138-145
33. McKay J.R., Alterman A.I., Koppenhaver J.M., Mulvaney F.D., Bovasso G.B., and Ward K. Continuous, categorical, and time to event cocaine use outcome variables: degree of intercorrelation and sensitivity to treatment group differences. Drug Alcohol Depend. 62 (2001) 19-30
34. McLellan A.T., Kushner H., Metzger D., Peters R., Smith I., Grissom G., Pettinati H., and Argeriou M. The fifth edition of the addiction severity index. J. Subst. Abuse Treat. 9 (1992) 199-213
35. McLellan A.T., Lewis D.C., O'Brien C.P., and Kleber H.D. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA 284 (2000) 1689-1695
36. McNeely J., Arnsten J.H., and Gourevitch M.N. Improving access to sterile syringes and safe syringe disposal for injection drug users in methadone maintenance treatment. J. Subst. Abuse Treat. 31 (2006) 51-57
37. Metzger D.S., and Navaline H. HIV prevention among injection drug users: the need for integrated models. J. Urban Health. 80 (2003) 59-66
38. Morral A.R., Belding M.A., and Iguchi M.Y. Identifying methadone maintenance clients at risk for poor treatment response: pretreatment and early progress indicators. Drug Alcohol Depend. 55 (1999) 25-33
39. Muller J.J., Creed P.A., Waters L.E., and Machin M.A. The development and preliminary testing of a scale to measure the latent and manifest benefits of employment. Eur. J. Psychol. Assessment 21 (2005) 191-198
40. National Academy of Sciences (Committee on the Prevention of HIV Infection among Injecting Drug Users in High-Risk Countries), 2006. Preventing HIV Infection among Injecting Drug Users in High Risk Countries: An Assessment of the Evidence. National Academies Press, Washington, DC.
41. Paone D., Clark J., Shi Q., Purchase D., and Des Jarlais D.C. Syringe exchange in the United States, 1996: a national profile. Am. J. Public Health 89 (1999) 43-46
42. Platt J.J. Vocational rehabilitation of drug abusers. Psychol. Bull. 117 (1995) 416-433
43. Saxon A.J., Wells E.A., Fleming C., Jackson T.R., and Calsyn D.A. Pre-treatment characteristics, program philosophy and level of ancillary services as predictors of methadone maintenance treatment outcome. Addiction 91 (1996) 1197-1209
44. Sees K.L., Delucchi K.L., Masson C., Rosen A., Clark H.W., Robillard H., Banys P., and Hall S.M. Methadone maintenance versus 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial. JAMA 283 (2000) 1303-1310
45. Sherman S.G., Fuller C.M., Shah N., Ompad D.V., Vlahov D., and Strathdee S.A. Correlates of initiation of injection drug use among young drug users in Baltimore, Maryland: the need for early intervention. J. Psychoactive Drugs 37 (2005) 437-443
46. Silverman K., and Robles E. Employment as a drug abuse treatment intervention: a behavioral economic analysis. In: Chaloupka F.J., Bickel W.K., Grossman M., and Saffer H. (Eds). The Economic Analysis of Substance use and Abuse: An Integration of Econometric and Behavioral Economic Research (1999), University of Chicago Press, Chicago 279-299
47. Simpson D.D., Joe G.W., Fletcher B.W., Hubbard R.L., and Anglin M.D. A national evaluation of treatment outcomes for cocaine dependence. Arch. Gen. Psychiatry 56 (1999) 507-514
48. Sorensen J.L., and Copeland A.L. Drug abuse treatment as an HIV prevention strategy: a review. Drug Alcohol Depend. 59 (2000) 17-31
49. Stitzer M.L., Petry N., and Silverman K. Contingency management therapies. In: Strain E.C., and Stitzer M.L. (Eds). The Treatment of Opioid Dependence (2006), Johns Hopkins University Press, Baltimore 151-177
50. Strain E.C., Bigleow G.E., Liebson I.A., and Stitzer M.L. Moderate- vs high-dose methadone in the treatment of opioid dependence. JAMA 281 (1999) 1000-1005
51. Strathdee S.A., Ricketts E.P., Huettner S., Cornelius L., Bishai D., Havens J.R., Beilenson P., Rapp C., Lloyd J.J., and Latkin C.A. Facilitating entry into drug treatment among injection drug users referred from a needle exchange program: results from a community-based behavioral intervention trial. Drug Alcohol Depend. 83 (2006) 225-232
52. Tyndall M.W., Currie S., Spittal P., Li K., Wood E., O'Shaughnessy M.V., and Schechter M.T. Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS 17 (2003) 887-893
53. Van Den Berg C., Smit C., Van Brussel G., Coutinho R., and Rins M. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam cohort studies among drug users. Addiction 102 (2007) 1454-1462
54. Wodak A., and Cooney A. Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence. Subst. Use Misuse 41 (2006) 777-813
55. World Health Organization, 2004. Effectiveness of sterile needle and syringe programming in reducing HIV/AIDS among injecting drug users. (Evidence for action technical papers). Geneva, Switzerland.